CD69 and neoplasm: Interestingly, tumor sizes from MRI data on the day prior to tracer injection, between doses on ICI, did not correlate with either survival or CD69 SUV signals in the ICI-treated group, and MRI on day 6 could not provide evidence of difference between the treatment groups.